Global X Genomics and Biotechnology (GNOM) News

BGI-Shenzhen Completes Acquisition of Complete Genomics
By PR Newswire, March 18, 2013, 02:19:00 PM EDT Vote up loading




Combined Company to Focus on High Volume, Accurate Human Genomic Sequencing and Accelerating the Spread of Genomic Medicine
SHENZHEN, China and MOUNTAIN VIEW, Calif., March 18, 2013 /PRNewswire/ -- BGI-Shenzhen ("BGI"), a leading international genomics organization based in Shenzhen, China, today announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has successfully completed the acquisition of Complete Genomics, Inc. (formerly NASDAQ:GNOM) ("Complete"), an innovative leader in accurate whole human genomic sequencing.

BGI accomplished the acquisition through a cash tender offer to purchase all of Complete's outstanding shares of common stock for $3.15 per share, followed by a short-form merger effective March 18, 2013.

BGI will operate Complete as a separate wholly-owned subsidiary and offer a broad array of genomic research technology across a variety of platforms. Dr. Clifford Reid will remain as CEO of Complete. The company has retired its ticker symbol, GNOM.[color=red][/color]

"We are delighted to now join forces with Complete," said Dr. Wang Jun, CEO of BGI. "We greatly value the employees and the work of Complete, which will benefit our genomic research by its complete and accurate whole human genome sequencing technology. We look forward to working together to support the advancement of innovative biotechnology, healthcare and other related fields."

"Complete and BGI share a vision of how whole genome sequencing can revolutionize clinical medicine," Dr. Reid said. "Before the end of this decade, I expect people around the world to routinely receive medical advice and treatment based on their own unique genetic makeup."

Advisors

Citi served as financial advisor for the transaction to BGI and O'Melveny & Myers LLP was BGI's legal counsel. Complete was advised by Jefferies & Company, Inc. and its legal counsel Latham & Watkins LLP.

About BGI

BGI includes both private non-profit genomic research institutes and sequencing application commercial units that provide comprehensive sequencing and bioinformatics services for medical, agricultural and environmental applications. Our commercial activities help our customers achieve their research goals by delivering rapid, high-quality results using a broad array of cost-effective, cutting-edge technologies. Our customers also benefit from our scientific expertise and research experience that have generated over 250 publications in top-tier journals such as Nature and Science. BGI is recognized globally as an innovator for conducting international collaborative projects with leading research institutions to better mankind and our world. Additional information about BGI and its U.S. subsidiary, BGI Americas, can be found at www.genomics.cn/en and www.bgiamericas.com.

About Complete

Through its pioneering sequencing-as-a-service model, Complete provides the most accurate whole human genome sequencing available today. The ease of use and power of Complete's advanced informatics and analysis systems provide genomic information needed to better understand the prevention, diagnosis, and treatment of diseases. Additional information can be found at http://www.completegenomics.com.



Read more: http://www.nasdaq.com/article/bgi-shenzhen-completes-acquisition-of-complete-genomics-20130318-01019#ixzz2NyrAcmaG

..

BGI-Shenzhen Successfully Completes Tender Offer For Complete Genomics, Inc.
PR NewswirePress Release: BGI-Shenzhen – 32 minutes ago...
.


Email






Print
...

.
.

RELATED QUOTES.
.


Symbol

Price

Change


GNOM 3.14


.
.
..

.
.


SHENZHEN, China, March 15, 2013 /PRNewswire/ -- BGI-Shenzhen ("BGI") announced today that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has successfully completed its all cash tender offer (the "Offer") to purchase all outstanding shares of common stock of Complete Genomics, Inc. (GNOM) ("Complete"). The Offer expired at 11:59 p.m. (New York City time) on Thursday, March 14, 2013. The Depositary for the Offer has indicated that, as of the expiration of the Offer, approximately 31,403,880 shares, or approximately 88%, of the common stock of Complete were validly tendered in and not withdrawn from the Offer, including shares of common stock of Complete subject to guaranteed delivery procedures. Beta Acquisition Corporation accepted all such validly tendered shares and payment for such shares will be made promptly in accordance with the terms of the Offer.

Beta Acquisition Corporation intends to exercise its "top-up" option and thereafter will own sufficient common stock of Complete necessary to effect a "short-form" merger under Delaware law, pursuant to which Complete will become a wholly-owned subsidiary of BGI, without the need for a meeting of Complete shareholders. In connection with the short-form merger, each outstanding share of Complete common stock will be converted into the right to receive $3.15 per share, the same price per share paid in the tender offer. Upon completion of the merger, Complete's shares will cease to be traded on the NASDAQ Global Market. BGI's financial advisor is Citi, and its legal counsel is O'Melveny & Myers LLP. Complete's financial adviser is Jefferies & Company, and its legal counsel is Latham & Watkins LLP.

Not able to sell @$3.15 on the market.

I haven't seen any official announcement, but I believe as of the last deadline they had enough shares tendered. I would expect to see an announced completion of the sale soon.

Opti

Any body know what will happen after today dead line. I am still holding.

BGI-Shenzhen and Complete Genomics, Inc. Receive CFIUS Clearance for BGI-Shenzhen's Proposed Acquisition of Complete Genomics, Inc.
Press Release: BGI-Shenzhen – 13 hours ago.. .
.http://finance.yahoo.com/news/bgi-shenzhen-complete-genomics-inc-022800420.html
SHENZHEN, China and MOUNTAIN VIEW, Calif., Dec. 28, 2012 /PRNewswire/ -- BGI-Shenzhen ("BGI") and Complete Genomics, Inc. (GNOM) ("Complete") announced today that they have obtained clearance from the Committee on Foreign Investment in the United States ("CFIUS") regarding BGI's proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete.

BGI's financial advisor is Citi, and its legal counsel is O'Melveny & Myers LLP. Complete's financial adviser is Jefferies & Company, and its legal counsel is Latham & Watkins LLP.

Stockholders with questions about the Offer or who need assistance with tendering their shares of common stock of Complete, may call the Information Agent, Innisfree M&A Incorporated, toll-free, at (888) 750-5834.

http://finance.yahoo.com/news/u-sees-coordinated-foreign-strategy-194131864.html

U.S. sees "coordinated" foreign strategy to acquire U.S. technology
WASHINGTON (Reuters) - The U.S. intelligence community is warning that "one or more foreign governments" appear to have a "coordinated strategy" to acquire valuable American technology by buying U.S. firms, a U.S. government body said in an annual report.
The finding was mentioned in the public version of an annual report to Congress by the Committee on Foreign Investment in the United States, an interagency body that reviews foreign investment for potential national security concerns.
One investment now before the committee is Chinese state-owned CNOOC's purchase of Canadian energy producer Nexen Inc. Ottawa has approved the deal, but CFIUS is reviewing whether to allow CNOOC to acquire Nexen's oilfields in the Gulf of Mexico.
The report, issued on Thursday, said the U.S. intelligence community "judges with moderate confidence that there is likely a coordinated strategy among one or more foreign governments or companies to acquire U.S. companies involved in research, development, or production of critical technologies for which the United States is a leading producer."
The public version did not identify any particular country but said information supporting the intelligence community's assessment was provided in the classified version of the report that was sent to Congress.
U.S. government officials have publicly complained about Chinese government policies that pressure American companies to transfer valuable technologies to do business in China.
That issue was on the agenda for high-level U.S.-China talks this week in Washington, with the United States welcoming a new Chinese pledge not to make technology transfer a condition for market access.
The U.S. business community has also complained about growing theft of U.S. trade secrets by Chinese companies, often by means of sophisticated cyberattacks.
The United States and China also agreed this week to hold technical talks next year on cybersecurity.
Last month, the U.S.-China Economic and Security Review Commission urged Congress to conduct an in-depth assessment of Chinese cyberspying and consider imposing tougher penalties on companies that benefit from industrial espionage.
The advisory panel, created by the U.S. Congress, also urged tougher U.S. scrutiny of all Chinese investment by state-owned enterprises.
"China is engaged in a state-directed coordinated strategy to acquire critical U.S. assets important to our economic and national security," commission member Michael Wessel told Reuters on Friday, saying he was reflecting his own views.
"Just in the last few weeks, we have seen an accelerated buying spree by Chinese companies with ties to the state," Wessel said, referring to a bid by BGI-Shenzhen to buy U.S. life sciences company Complete Genomics and investments made by Chinese petroleum company Sinopec in Wyoming.
(Reporting By Doug Palmer; Editing by Neil Stempleman)

Illumina Stock Falls As Analyst Warns Of Competition

By Amy Reeves, Investor's Business Daily

Gene-analysis giant Illumina's (ILMN) shares were down 3% in afternoon trading Monday after an analyst downgraded the stock, but they had been down 7% early in the day.

Robert W. Baird analyst Jeffrey Elliott wrote that the stock's valuation, which hit an eight-month high on Friday, was driven by rumors that Roche (RHHBY) might make another bid for Illumina, which it attempted to take over for $8.7 billion earlier this year. But Elliott noted new competitive threats from Life Technologies (LIFE) and Oxford Nanopore, and noted possible complications in Illumina's relationship with its largest customer, BGI, as they're both bidding to buy Complete Genomics (GNOM). Even if Illumina wins, the merger "would raise integration risk and require sizable investment, in our view," Elliott wrote.

Illumina's stock has been through some wild ups and downs in the last 18 months, but has regained a highest-possible IBD Composite Rating of 99 since its last quarterly report on Oct. 23. That quarter, double-digit profit and sales growth resumed after four flat quarters in a row, and analysts expect EPS growth in the teens through next year.


Read More At IBD: http://news.investors.com/technology/112612-634614-illumina-shares-fall-from-high.htm#ixzz2DOGC8N37

Illumina Sends Letter to Complete Genomics Board, Expecting No Antitrust Issues with Bid
8:59a ET November 21, 2012 (Benzinga) November 20, 2012

Board of Directors

Complete Genomics, Inc.

2071 Stierlin Court

Mountain View, CA 94043

Gentlemen:

I was disappointed to learn that the Board of Directors of Complete Genomics, Inc. summarily rejected Illumina, Inc.'s proposal to enter into a business combination transaction in which Illumina would acquire Complete Genomics, Inc. at a price of $3.30 in cash for each outstanding share. We believe, and think that Complete Genomics shareholders would agree, that our Proposal is superior to the proposed acquisition by BGI Shenzen for $3.15 per share. The price per share offered under our Proposal represents a premium of 5% to the BGI proposal. Our Proposal is not subject to any additional due diligence, and unlike the proposed BGI transaction is not contingent on financing or CFIUS approval. With respect to antitrust approvals, we are confident that our proposed transaction would be approved, and raises fewer regulatory concerns than the proposed BGI transaction. In light of that, we cannot comprehend how your Board of Directors could rationally come to the conclusion that our Proposal is not superior to BGI's proposal, or how rejection of our Proposal without discussion could satisfy your Board's obligation to the shareholders of Complete Genomics.

Your agreement with BGI allows Complete Genomics to engage in transaction discussions with others if your Board of Directors determines that a third party proposal is, or could reasonably be expected to result in, a “Superior Proposal”; i.e., a proposal that is (1) more favorable to Complete Genomics shareholders from a financial point of view than the BGI proposal, and (2) reasonably capable of being consummated on the terms proposed. We believe that our proposal meets both criteria. In addition to providing demonstrably superior value, we believe our Proposal can be consummated on the terms proposed and, in fact, offers your shareholders greater closing certainty than BGI's proposal for the reasons discussed below.

BGI's proposal is subject to a number of conditions including, among other things, (1) receipt of financing, (2) approval of the Committee on Foreign Investment in the United States (“CFIUS”) under the Exon-Florio Act, and (3) expiration or termination of the waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act. More than two months after having announced your proposed transaction with BGI, these conditions have not yet been satisfied. In fact, you recently received a “second request” from the FTC, indicating sufficient antitrust concerns to merit an investigation under the HSR. Furthermore, while you have made no disclosure of the status of your CFIUS filing, we believe that there are serious concerns raised by your proposed transaction with BGI that call into question whether that transaction can be completed. In contrast, our Proposal is not subject to any conditions relating to financing or CFIUS approval.

--------------------------------------------------------------------------------

National security, industrial policy, personal identifier information protection and other concerns raised in connection with an acquisition of Complete Genomics by a foreign state owned entity create meaningful uncertainty around a BGI acquisition, and represent a material risk for your shareholders. As you may be aware CFIUS reviews of transactions involving state owned entities have been problematic, and several transactions have been abandoned rather than be subjected to a Presidential order to unwind the transaction. Recently the President issued an order to unwind such a transaction in an industry far less sensitive than ours.

While expiration of the HSR waiting period is necessary in order to consummate our proposed transaction, we believe that our Proposal can be consummated under applicable antitrust laws, and that our combination raises fewer regulatory concerns than the BGI proposal. In light of that, your public statements characterizing Illumina's views on the antitrust aspects of the combination of our two companies - as well as comments attributed to our CEO and antitrust counsel - are inaccurate. Furthermore, your suggestion that BGI is better positioned to proliferate the technology in the marketplace, and therefore more pro-competitive, reflects a lack of understanding of Illumina's intentions and the competitive market dynamics.

As you know, the markets in which we operate are rapidly evolving and highly competitive, in significant part because of game-changing innovations by Illumina and Complete Genomics. The combination of our companies will accelerate the pace of such innovations and result in higher quality, more innovative products available at lower costs to consumers. This combination will also further stimulate global competition in sequencing services as well as in the emerging business of genome analysis and interpretation. We believe that more significant issues for consumers and the industry are raised by the combination of Complete Genomics with a state owned entity such as BGI that is primarily focused on sequencing services than by a primarily equipment-consumables company like Illumina.

Our Proposal has been approved by our Board of Directors and we are prepared to enter into an agreement on substantially the same terms as the agreement you entered into with BGI including the bridge financing. In this regard, we are providing you with a form of merger agreement and financing agreement that we are prepared to enter into subject to your compliance with your agreement with BGI. We have engaged Goldman, Sachs & Co. and Skadden, Arps, Slate, Meagher & Flom LLP as our financial and legal advisors, and are ready to meet with you at any time to discuss this Proposal in accordance with your agreement with BGI.

Again, I believe the combination of our two companies is a tremendous opportunity for our respective shareholders, customers, and employees. I sincerely hope that your Board and management will consider the best interests of these constituencies and seek to complete this transaction promptly.

Very truly yours,

/s/ Jay T. Flatley

Jay T. Flatley

President and Chief Executive Officer

11:33 AM BGI-Shenzhen has again extended the deadline for its tender offer to acquire Complete Genomics (GNOM +1.6%), a move that comes in response to Illumina's (ILMN +0.8%) recently disclosed competing bid earlier this month that was rejected by the life sciences company. BGI's tender offer now expires on December 14.

Illumina Says It Was Second Bidder for Complete Genomics

By Ryan Flinn - Nov 16, 2012 5:15 PM ET.
.

Illumina Inc. (ILMN), the U.S. leader in genetic sequencing, said it had offered $3.30 a share to acquire rival Complete Genomics Inc. (GNOM), or 5 percent more than the bid from BGI-Shenzhen that was accepted by the company.

Complete Genomics considered Illumina’s offer “inadequate” because of the likelihood the deal wouldn’t receive clearance from antitrust regulators, the Mountain View, California-based company said today in a filing. The company named the bidder only as “Party H.”

BGI-Shenzhen, a Chinese operator of genome-sequencing centers, agreed to acquire Complete Genomics in September for $3.15 a share, or about $117.6 million, to expand in the U.S. market for medical and research DNA testing. The board of Complete Genomics has unanimously recommended that stockholders accept BGI’s offer.

Illumina, based in San Diego, said in a filing today that its offer was in cash and came without “any condition for further due diligence.”

To contact the reporter on this story: Ryan Flinn in San Francisco at rflinn@bloomberg.net

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net

Somebody knew something well before it happened and wanted to get the word out but had to do so anonymously. Look at these sites

biotech-buyout-rumors.blogspot.com

nasdaqnewsreports.blogspot.com

Take a look at their posts in July. Similarly timed, similar theme and price target that did not materialize. Now both sites have posted again recently on another stock. I tell you this because I felt ripped off having to sell in the low 3's (basically breakeven on a BUYOUT) and I know a lot of other people got ripped off worse. So I find it only fair to spread what they have to say because they obviously know something in this farce called the NASDAQ.

The problem is that this BOD for this company stinks.

They do all their deals in the back room wiht special $$ for themselves and nothing for the shareholder.

They stink, period.

Opti

A gap up today? Hmmm........GNOM back on radar here - chart doesn't look all that bad either -

all the best for you Josh

keep in touch

Opti

No worries. I read the post on AONEQ and figured they would delete it quickly, which they did. I learned my lesson about being greedy very well with AONE, at the cost of $6,000+ swing. I knew I was gambling with it, but thought it would work out and was just being blind to the real facts. I think the shares will wind up worthless and thats why they were pushing the KEIP so much, especially wanting it with no cap.

Im out of it until I hear the stock will have some value, which I dont think will occur. Only play I may do on it is trade the 1030 or 230 dip if I want to gamble.

I havent looked into ENOL yet, but with the money I sold AONE for, I went on a limb and put 5K into VRNG at 3.20 (have a total of 2300 shares averaged in now at 3.15 or so). Up around 7% today and hoping with good news it will take care of all the AONE debt and a bit more....Hoping again....never a good strategy but you have to catch a break sometime right? haha

AONE could have another run it it. I still have enough shares to wait a week or two, but not longer without absolute positive news.

Who Knows?

Good fortune.

JP

Good for you and glad you made money on it! I know it doesn't recoup the loss from gnom, but its a start in the right direction and I appreciate the email earlier and you being honest with me as well about selling.

Not real sure what to think about the court hearings today- good or bad. AH helped again tonight, which I hope is a good sign for things to come, at least short term. I plan on trying to exit when I can so that I don't take to big of a hit. I would have loved to sold at 0.19 as well and taken that profit and stick into VRNG. I bought in at 4.73 (mid-height of pump, and watched it sink to 2.20, bought in again at 2.50 and 3.05 the other day. Was getting ready to double down today and sell some AONE and buy more at 3.30 but got scared and didn't. Presumed to watch it trade up to 3.95 at close and 4.12 in AH. You live and you learn though I guess. Sitting good right now at average of 3.13 a share and the big news hasn't came out yet as to if they have won against google and how much will be awarded...hoping it makes up for AONE and more!

sold most of my holdings today at .124. $2k profit. Not the $20k profit I would have realized at .19, but profit nontheless.

Still holding 100k shares but will sell those if we have another gain.

Too confusing for me to hold. I have no clue as to where this is headed, but it can't be good.

JP

I have questions back and forth with John Peterson on this issue. He says they own nothing.

I am trying to understand the following:

Reporting Person Number of Shares of Percentage of Number of
Common Stock Outstanding Shares Outstanding Shares
Beneficially of Common Stock2 of Common Stock3
Owned1,2
Wanxiang Group 34,839,097 9.99% 348,739,707
Wanxiang America 34,839,097 9.99% 348,739,707
Wanxiang Foundation 34,839,097 9.99% 348,739,707
Guanqiu Foundation 34,839,097 9.99% 348,739,707
Dr. Lu 34,839,097 9.99% 348,739,707

This is from
http://bit.ly/RAdlMf 13D&filingDate=10/...

Does this not give Wanxiang incentive to maintain share value.

John Petersen 53584
No it doesn't. The Form 13D/A Wanxiang filed with the SEC on October 15th is here.

http://1.usa.gov/WgHcfy

The SEC's beneficial ownership rules require a holder like Wanxaing to report both shares owned, and shares that can be acquired on the exercise of warrants and options.

When Wanxaing made the first bridge loan advances to A123, it got a bridge loan warrant that can be exercised to buy shares one of two ways. Wanxiang can either write a check for the exercise price, or exchange its secured debt for the exercise price. Neither event seems likely until the Bankruptcy is resolved because the secured creditor position is so much more advantageous than the stockholder position.

So what do you take from that recent filing saying that they own close to 50% already???

Just sent you an email in regards to the one you sent me. I think that getting in touch with writers actually sounds like a great idea. I will contact seeking alpha and may try a few more. Worst thing they can do is say no or not respond!

Josh: trying to drum up more interest in the issue of stockholder interests, I am emailing the writers of any article on the bankruptcy suggesting that they write an article on shareholder value going into and coming out of the bidding process.

Who knows, maybe one will stir things up.

What I heard from the court was certainly not promising. How are we to afford lawyers to look after our interests?

I am still hopeful this judge will ask quesstions of the bidders regarding common share holders.


Opti

If youre not watching, its running hard right now..in the past 10 minutes it went from the LOD, 0.1227, to no 0.1347 in the matter of a few minutes. 0.136 hitting hard now with only a about 5 sales in the time period.

same here on hitting my limit, and already half way through on them today- may sign up for the free 2 week thing today.

But since really noone reads this board anyways, feel free to email me at josh.lykins2010@gmail.com if you see anything big come out.

Thanks.

Josh: couple of new things:

1. there is a person following all this and posting on both twitter and facebook:

Ilene Slatko
@DelShareholder
Re: AONE I've just spoken to the Court regarding the potential impact of Sandy, if in fact, we get the hurricane... fb.me/1Z0YbcB7J
2:26pm Fri Oct 26

http://www.facebook.com/notes/delaware-shareholder-services/a123-first-day-motions-1018/472188116164768

Ilene: do you know THJKC's history with regard to shareholders? Is he one to "watch out" for shareholders' interests?

3 hours ago · Like..

Delaware Shareholder Services John, I am looking at some of his decisions now, to better answer your question. This is the 2nd or 3rd bankruptcy in his courtroom that I've been part of...and the one comment I can make about THJKC is that he asks questions and makes comments frequently from the bench...so his thoughts about the case are telegraphed more than judges who sit mostly in silence and then issue opinions. I'll be back to you on this...

about an hour ago · Like


2. I have emailed several people that might know this judge to see if he is ever common share holder friendly.

3. I even emailed the judge: good luck with that

More if I hear anything. I will try to post late in the day with a consolidation of emails as I hit my limit yesterday and will want to conserve today.

Opti

If the common stock is cancelled, what does that mean for all the shorts, so something like 15-17% of the float right now I believe? I thought if your are short and a company goes bankrupt, you don't have to pay taxes in those gains, but what about if the shares are worthless?

Everyone lose? I'm hoping for a good day today, and may look at getting out if it gets in the higher teens today.

Wow that doesn't sound to good from those responses. Who wouldn't want to come in and get a billion dollar company and not have to pay the shareholders on top.

Do you think that's why the bids are so low? If they are just basically bidding on the assets of the company and not so much setting a price or giving any consideration to the common stock?

If the Johnson bid is accepted, what happens to the common stock?

Hard to say at this point, but through the reorganization process, the common stock could be canceled with no value. Please see our Investor FAQ at www.a123systems.com/about-us-asset-purchase-agreement-and-chapter-11-filing.htm for more information.

Can AONE reverse their bankruptcy intention?

We filed a petition for Chapter 11 bankruptcy protection because we missed two debt payments – that can’t be reversed

What are companies bidding for? What is up for bids?

Johnson controls and others are bidding for assets under reorganization

What influence do the bids have on share price and why?

Impact on common shares depends on the outcome of bankruptcy court

What is the value of the common stock under the various scenarios? High and Low.

I can’t speculate on share price. See also #1 above

What are the key dates going forward? Does risk increase or decrease October 30 and November 9?

Depends on what you think of as key. Bankruptcy court dockets are available at www.loganandco.com/Disclaimer.aspx?Ret=%2fClientSummary.aspx%3fDebtorID%3d381%26DebtorTabID%3d3529 and include hearing dates

What happens when the judge rules on the highest bidder?

There could be multiple bidders for various assets and the bankruptcy court guides the reorganization process

What is the end game for common shares?

See #1

Trading is purely a hobby. I got hooked 25 years ago when I bought stock in Telephonos de Mexico. Make enough money to pay off my house and car.

Built it back up and lost it all on OZON. Went on a missions trip to Cuba with the stock at 0.41 and returned to find it at 0.04. Today it is at 0.0013.

Had a big win two years ago on SIRI, paid for two new cars.

Latest fiasco was GNOM, but AONE may win it back.

Other plays include GTAT, JDSU, LDK, and of course GNOM.

Always looking for something new, althougth a nice safe play would be nice.

All my retirement money is in guaranteed return; none of it in the market.

Off to a viewing tonight.

Check back in late this evening. Hoping for an uneventful AH trading session.

Opti

Filled another 12,000 at 0.1338 which I didnt think would get filled, now looking like I should have put it in for 13 or 125....I just hope this is the day traders selling out to be in $$ by the end of day. we need a good push the last minute! Thought we were going to get it but looks like we are going to close at 133. Nice big buy at the end with 59523.

I liked your post on the AONE board about knowledge today as well. I dont understand why people get so happy to see others losing money, I guess because they are short and making money themselves? Ive never shorted a stock and think that I should start seeing that whenever I buy one it always goes down. haha

So if you dont mind me asking, how long have you been trading? Full time thing or do you work as well as this on the side?

I do like that they own 80 million shares. Share price should be important to them.

I do not like the swings this stock is taking on a daily basis. Probably the day traders, but it makes it hard to break through reisitance at 0.20, which is what we have to do to make me happy.

People are afraid to hold this over night. After hours is just too scary, and we do know it can swing wildly after hours.

Here is hoping for a peaceful, uneventful night.

Opti

I like the private AONE board here as well. Pretty sure noone has been on this board in the past 2 months except us anyways.

There are 2 things that scare me about WAX:

1. If they do not get the bid then they have 80 million shares that would be getting dumped into the market, unless they would hold to try and get the higher PPS that may be offered. But if they would dump all those shares, this thing would go down next to nothing..

2. If they do win the bid for the company, since they own 80 million shares already, do you think they may just do the cancelation of the shares? Since they own so much, it would help them have a bigger say in the right for the takeover. I know they wouldnt pay themselves back for the shares they bought, and possibly not for any of the remaining shares.

One good thing I saw on that list, though, was it was WAX AMERICA and not the Chinese based WAX. Man its tanking right now....

Seems like we have our own private AONE board here. I like it. Too much clutter on the other thread.

Tuesday's drop, especially after hours was a definite scare.

I like the list of interested parties, but wish one of them was able to place a public bid. Also wish AONE would withdraw their bankruptcy petition and simply solicit buyout bids. Then it would be pretty risk free.

I do not like the prospect of after hours news.

0.30 would be such an easy decision for me.

anything less than 0.20 is just not convincing.

We shall see.

Opti

Being new to investing on my own I have seen the downfalls of not fully understanding things and throwing money in at things blindly. Started to be able to see trends now and reading charts better, but have lost out not taking profits when I have been able to. Something I need to work on for sure. Also need to work on setting a stop loss on things as well. I Hate losing money more than anyone else, and looking at my P&L right now, Im holding several in red. The ones Ive sold since I started 6 months ago Im up pretty good, but the ones Im still curently holding onto, well those trump the profits thus far.

0.15 is about my breakeven point and anything above that is profit. Ive been in the green in this stock only about 3 or 4 times in the last 3 months, once in August after the buyout talks, didnt trade it, and then when we hit the 15-19s a couple days back- didnt trade them and was up 2k. I would love for it to hit in the mid 20s, 30s, but have no clue to what it will do, especially in AH. Im not sure why someone would come out with an article either putting a $1.50 price tag on AONE as many have posted about on the AONE board- doesnt make any since to me. I cant really see it being painted as a pump this late in the game. If the original offer of 450s by WAX would put a targe of 0.55 on the stock, then the 125 offer would be roughly around 0.152. But that does not include the assests of around 450 million, or if it stays in the US they may be able to keep the remaining DOE money, I think roughly around 120 million left or so. If someone just wanted to come in and buy this and then sell everything off they could make several million.

Who knows and now just feeling like Im rambling. Not selling today unles we hit 17s before market closes, and not seeing that in the works right now. I plan on buying more if it dips in the mid 13- but if that happens then it looks like there really isnt a whole lot of support until 10s or 11s.

What did you take out of post 9088 by daddy fat saxx:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=80896391

This thing could blow up if they each have to outbid one another by at least 10-15 million.

Thanks, Josh. Still looks like a dice game to me. Roll the dice and take your chances.

Very glad to see us on the upswing today.

Trying to figure out where I start selling portions of my holdings.

Also trying not be be greedy, but instead happy we are not back at five cents.

Opti

Buyouts

A buyout occurs when another company buys the bankruptcy business and absorbs it. The bankrupt owners are often glad to have a buyer, which allows acquiring corporations to negotiate for lower prices. After a buyout, stockholder position is determined largely by the actions of the buyer. Buyers may transfer stock in the old company into their own stock. The transfer rate may not be good--several shares of old stock may be traded in for the buyer's stock--but the stockholders have a small return. Other buyers may buy all stock of the old business for a fraction of its price.

Cancellation

In a worst-case scenario, the company's stock will be canceled. This can occur if a buyer does not want to deal with the old shares at all, or if the Chapter 11 was unsuccessful and the business cannot keep operation. Chapter 11 often leads to Chapter 7 bankruptcy and stock cancellation. In this case, stock continues to trade for a short time but is ultimately ended. Investors who cannot sell their shares lose their money.


Risk

Stockholders also lose when it comes to risk in a bankruptcy. For a Chapter 11, the court may require the business to pay back primary creditors. This will certainly happen if the business files Chapter 7. But stockholders do not benefit from this arrangement. First the business will pay off large lenders. This usually takes all the funds of a failing business. Next, if any funds are still available, the business will pay off bonds. Stocks come last, and although preferred stock is paid out before common stock, the business will rarely have any funds left to allow stockholders to recover their losses.
-------------------------------------------------------------------
So far from what Ive seen and read, it looks like AONE is doing what they can to dodge the bullets listed above- filing for Chpt 7; If Wax does win the bid for the company, I cant see them cancelling the common stock since they own so much already and with the court granting AONE to continue with opperations at the plants (giving paychecks, insurance still good) it seems to me that chapter 7 isnt being considered.

I held all my shares today and have been watching the L2 now for close to 6 hours. I actually wired in another 2K into my account if I felt it was a good time to "pull" the trigger and buy more. I think we may see a dip at 230, if the chart holds true to the past couple days, and then finish on a HOD in power hour. If we can break the 0.155s mark, we fly into the 16s and then on to the -18s it looks like. But who knows how many of the MMs will repost with a higher ASK then what the L2 is showing now.

GNOM is so interesting, but very difficult to get a professional read on. Of the six million shares tendered, 80% are from the directors. Looks like the common man said no thanks. I will watch this closely to see if I should buy it back some day.

On AONE, I am not a daytrader, so no way will I try to sell and buy back. However, I do have too many shares (over 250,000), so I will start paring that down in 50,000 share increments. Looking to narrow my holdings sometime today or tomorrow, but also looking for volume over 100 million shares to make the sale certain at a reasonable price.

I would love to see some positive news. I also wish we could get a professional opinion on what exactly is happening with regard to the bankruptcy, the potential bidders, and the common stock.

Opti

Makes since. With them extending the tender offer by another month it makes you wonder if they are going to get it rejected. I thought I read that only around 6 million shares or so had been tendered thus far. Well off from what they thought they may get, IMO. I keep an eye on it ever day to see what it does and see if any new news surfaces.

So any thoughts on AONE? Im up around $500 on it right now with ~42000 shares. Do you think the regular dips with hold true today? usually starting around 10-1030 a dip happens, like it is now. Think selling and then buying in in the 14s is possible today? I have a margin account so all the sales money I could use

They probably sent it to shareholders as of a certain date.

Try to figure out what is going on with GNOM. Will it sell or not? I hope not and that somehow all the directors are fired for their sham attempt at selling the shareholders down the drain.

Now, with regard to AONE it appears we dodged a serious bullet. Lesson learned. I will start pealing off my shares once this reaches .20 again (if indeed I am fortunate enough to see that happen).

The whole market seems so stacked against the common man anymore. Crooked world, I guess.

Opti

I got that yesterday too and didn't really know what to think of it since I sold my shared already. I know it says they are extending the tender, but if I don't own any now, why send it to me?

Back to GNOM: message from eTrade

- Attention Brokerage Customer

Dear Valued Investor,
Please be advised that the offer has been extended.
RE: COMPLETE GENOMICS INC.
Cusip: 20454K104
Issue type: Tender.
Offer by: Beta Acquisition
Terms: $3.15 net per share.

INSTRUCTION DEADLINE: 11/19/12

There is a withdrawal privilege.
There is a 3 business day guaranteed (protect) period.
Please contact an etrade representative if you wish to participate.
(c) 2010 E*TRADE Clearing LLC, Member FINRA/SIPC. All rights reserved. E*TRADE Securities accounts are carried by an affiliate, E*TRADE Clearing LLC. The information contained in this Smart Alert does not constitute a recommendation by E*TRADE Clearing, and is subject to the Smart Alerts Terms and Conditions and the E*TRADE Securities Customer Agreement. We cannot respond to e-mails sent to this mailbox. If you have questions, please contact us through the Online Service Center.

This buying late is a good sign I hope. jumped 3% in about a minute. Super thin up to mid 11s it looks like. If it does tank Best of luck to you with everything! You may hear a cry tonight if it tanks! Wow up almost to 11 now...All the fingernails have been bit off over the past 2 days for sure! Thanks for all the help though and appreciate you checking back on this board since I dont have PM on my account.

I am staying in.

Opti

still holding. today started off as a flat line and mid day picked up to 12. Thought it was going to be a good start for us...now 10s....you out or still in till the 30th?

if we hold today and tomorrow and then hear that the delisting is not going forward, we should be safe for another week.

this could all change very quickly on either good news or bad. too bad this delisting issue came up yesterday; it is a bogus issue, but is probably what drove the price down.

now there is too much uncertainty to climb back, so we need good news--new bidders, leaked amount on one of the bids, change of mind from the company on bankruptcy, or ruling by NASDAQ that it stays listed for another 30 days.

take your pick on the good news; I think all the bad is built into the current price.

Opti

I agree- have a meeting at 10- hope it won't last more than 20-30 minutes- scary 30 minutes though without any updates.... :/

no news, just following the ticker and watching closely. Glad to see it holding above .113. Hoping it closes today somewhere north of .15, then builds back toward .20.

Still think I will be able to sell above .20, but I need to lessen my # of shares just in case it decides to tank again.

Opti

Good luck today! Heard any news?

I do not see a delisting. I am hoping we still have at least until October 30th and then November 9th. (deadline for filing offers with the court and then the court decision).

Certainly would be nice to be on the sideline, but we are not.

My shares are at .113

Opti